Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Potent and selective inhibitors of p56lck kinase developed at Celltech

Sep. 9, 1998

Licensing opportunity from the NIH: carrier for conjugate vaccines

Sep. 9, 1998

Licensing and/or CRADA opportunity: drug and method to prevent and treat graft-vs.-host disease

Sep. 8, 1998

Scripps patents guanine derivatives with immunostimulating activity

Sep. 4, 1998

Fujisawa announces marketing approval of Prograf in Mexico and launch in Taiwan

Sep. 3, 1998

Another rotavirus vaccine gives promising results in phase II testing

Sep. 3, 1998

FDA approves first vaccine for prevention of rotaviral disease

Sep. 1, 1998

Genset enters into Chlamydia vaccine license agreement with AHP

Aug. 28, 1998

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

Aug. 26, 1998

Laboratory testing of new, more efficient Toleragen drug completed

Aug. 25, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...